(Q52194439)

26 April 2018

title

NMDA receptor antagonists prevent conditioned activation of intracranial self-stimulation in rats. (English)

1 reference

26 April 2018

author

Anton Bespalov

series ordinal

1

1 reference

26 April 2018

author name string

E Zvartau

series ordinal

2

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 May 1997

1 reference

26 April 2018

European Journal of Pharmacology

published in

1 reference

26 April 2018

volume

326

1 reference

26 April 2018

issue

2-3

1 reference

26 April 2018

page(s)

109-112

1 reference

26 April 2018

Classical conditioning of electrical self-stimulation of ventral tegmental area to brief visual stimuli in rats.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

Intraaccumbens administration of NMDA receptor antagonist (+/-)-CPP prevents locomotor activation conditioned by morphine and amphetamine in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

The NMDA antagonist MK-801 can impair attention to exteroceptive stimuli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

The development of behavioral sensitization to apomorphine is blocked by MK-801.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

DNQX in the nucleus accumbens inhibits cocaine-induced conditioned place preference.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

Effects of NMDA receptor ligands on sensorimotor gating in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

Extracellular glutamate in the nucleus accumbens during a conditioned emotional response in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

Conditioned dopamine release: dependence upon N-methyl-D-aspartate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

Enhanced glutamatergic neurotransmission facilitates classical conditioning in the freely moving rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2985403-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(97)85403-9

1 reference

26 April 2018

PubMed ID

9196261

1 reference

26 April 2018